Logo
header-publicacoes-cientificas.jpg
Artigos Científicos

Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization a...

25 janeiro 2022
link

Copiado!

Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta

André Peralta-Santos, Eduardo Freire Rodrigues, Joana Moreno, Vasco Ricoca, Pedro Casaca, Eugenia Fernandes, View ORCID ProfileJoão Paulo Gomes, Rita Ferreira, Joana Isidro, Miguel Pinto, Vítor Borges, Luís Vieira, Sílvia Duarte, Carlos Sousa, José Pedro Almeida, Luís Menezes, Bibiana I. Ferreira, Ana Matias, Ana Pelerito, Samanta Freire, Teresa Grilo, Cláudia Medeiros Borges, Vera Moutinho, Andreia Leite, Irina Kislaya, Ana Paula Rodrigues, Pedro Pinto Leite, Baltazar Nunes

Abstract

Early reports showed that Omicron (BA.1) SARS-CoV-2 could be less severe. However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) infections compared with Delta (B.1.617.2) is not yet clear. This study compares the risk of severe disease among patients infected with the Omicron (BA.1) variant with patients infected with Delta (B.1.617.2) variant in Portugal.

Results

We included 15 978 participants aged 16 or more years old, 9 397 infected by Delta (B.1.617.2) and 6 581 infected with Omicron (BA.1). Within the Delta (B.1.617.2) group, 148 (1.6%) were hospitalized, and 16 (0.2%) were with the Omicron (BA.1). A total of 26 deaths were reported, all in participants with Delta (B.1.617.2) infection. Adjusted HR for hospitalization for the Omicron (BA.1) variant compared with Delta (B.1.617.2) was 0.25 (95%CI 0.15 to 0.43). The length of stay in hospital for Omicron (BA.1) patients was significantly shorter than for Delta (confounding-adjusted difference -4.0 days (95%CI -7.2 to -0.8). The odds of death were 0.14 (95% CI 0.0011 to 1.12), representing a reduction in the risk of death of 86% when infected with Omicron (BA.1) compared with Delta (B.1.617.2).

Newsletter

Quer ficar a par das novidades?
Subscreva a newsletter!

PessoasCiênciaSaúde

Escolha do ConsumidorGlobal Safe SiteLivro de Reclamações

Contactos

+351 222 401 401
Custo de chamada
para a rede fixa nacional
2ª a 6ª – 8h00 às 20h00
Sábado – 8h30 às 12h30

Siga-nos nas redes sociais

APP Saúde Unilabs

© Unilabs 2026 | Powered by  
.
.
check